Inequalities in green space linked to preventable deaths in urban areas

Findings reveal that more green space in deprived neighborhoods is associated with lower mortality rates, advocating for strategic public health initiatives.

Tevimbra by BeiGene for Muscle Invasive Bladder Cancer (MIBC): Likelihood of Approval

Tevimbra is under clinical development by BeiGene and currently in Phase II for Muscle Invasive Bladder Cancer (MIBC).

January 1, 2025

Widespread inhaler misuse in COPD patients: Need for training

Study found that 69% of hospitalized COPD patients misused inhalers, with 66% making critical errors, and 14% having insufficient Peak Inspiratory Flow (PIF), even after

August 25, 2024

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Hepatocellular Carcinoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.